Genetic Variation in &lt;i&gt;CYP2B6&lt;/i&gt;, &lt;i&gt;UGT1A4&lt;/i&gt; and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen. Here, CYP2B6 is linked to breast carcinoma.